TA
HBIO icon

Teton Advisors’s Harvard Bioscience HBIO Stock Holding History

Teton Advisors’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-15,639
Closed -$447K – 478
2016
Q2 		$447K Buy
15,639
+100
+0.6% +$3.18K 0.04% 377
2016
Q1 		$469K Sell
15,539
-3,563
-19% -$101K 0.04% 378
2015
Q4 		$663K Sell
19,102
-2,600
-12% -$88.9K 0.06% 352
2015
Q3 		$820K Buy
21,702
+439
+2% +$20.4K 0.06% 329
2015
Q2 		$1.21M Buy
21,263
+1,200
+6% +$68.3K 0.08% 292
2015
Q1 		$1.17M Buy
20,063
+6,441
+47% +$346K 0.08% 290
2014
Q4 		$772K Buy
+13,622
New +$649K 0.05% 344

Other funds holding HBIO

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Teton Advisors's HBIO Position: Q3 2016 in Review

Teton Advisors sold out of Harvard Bioscience (HBIO) in Q3 2016, closing a stake of 15,639 shares — an estimated $447K sold.

Teton Advisors first reported a position in HBIO in Q4 2014 and held it in 7 quarters. The position peaked at $1.21M in Q2 2015. 69 funds tracked by Wall St. Rank hold HBIO as of Q3 2016.

  • Teton Advisors reported no remaining Harvard Bioscience position as of Q3 2016 after selling out during the quarter.
  • Teton Advisors sold 15,639 Harvard Bioscience shares in Q3 2016, an estimated $447K.
  • Teton Advisors first reported a position in Harvard Bioscience in Q4 2014 and held it in 7 quarters.
  • Teton Advisors's Harvard Bioscience position peaked at $1.21M in Q2 2015.
  • 69 funds tracked by Wall St. Rank held Harvard Bioscience as of Q3 2016.

Based on Teton Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.